RapidAI stock

RapidAI Stock

HealthTech

Looking to sell RapidAI stock or options?

Contact us
Founded: 2011Funding to Date: $94M
Visit website

RapidAI operates a neuroimaging platform designed to generate high-quality images from non-contrast CT and MRI scans. The platform offers the capability for viewing, processing, and analyzing brain images, which aids clinicians in making precise diagnostic and therapeutic decisions for stroke patients. RapidAI's technology provides doctors with valuable assistance in the management of stroke treatment.

Investors Include:

Cullom Capital, Listwin Ventures, Lennertz & Co..